Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polska Grupa HutniczaWAR:PGH +8.77%31 Days Payable is 505.68 as of Mar. 2026, which is 101% above its 10-year median of 251.00. GuruFocus rates WAR:PGH with a GF Score™ of 31/100 and a GF Value™ of zł0.31 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 926 Drug Manufacturers companies, Polska Grupa Hutnicza ranks better than 89.85% on this metric.
Polska Grupa Hutnicza Days Payable Historical Data
* Premium members only.
The historical data trend for Polska Grupa Hutnicza's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:PGH vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Polska Grupa Hutnicza's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polska Grupa Hutnicza Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Polska Grupa Hutnicza's Days Payable distribution charts can be found below:
* The bar in red indicates where Polska Grupa Hutnicza's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Polska Grupa Hutnicza's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polska Grupa Hutnicza (WAR:PGH) has a Days Payable of 505.68 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Polska Grupa Hutnicza and its competitors. This is 101% above median its historical median of 251.00. Over the past decade, Polska Grupa Hutnicza's Days Payable has ranged from 54.43 to 5,910.19. According to the industry distribution chart, Polska Grupa Hutnicza ranks #94 out of 926 companies in the Drug Manufacturers industry, placing it in the top 10.2%.
Is Polska Grupa Hutnicza's Days Payable too high?
Polska Grupa Hutnicza's current Days Payable of 505.68 is 101% above median its 10-year median of 251.00. Over the past 10 years, this metric has ranged from a low of 54.43 to a high of 5,910.19. The Drug Manufacturers industry median Days Payable is 90.22. Polska Grupa Hutnicza's value of 505.68 is 460.5% above this industry median. Based on the distribution chart, Polska Grupa Hutnicza ranks #94 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Polska Grupa Hutnicza has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Polska Grupa Hutnicza's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Polska Grupa Hutnicza ranks #94 out of 926 companies for Days Payable. This places Polska Grupa Hutnicza in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.22. Polska Grupa Hutnicza's value of 505.68 is 460.5% above this benchmark. Historically, Polska Grupa Hutnicza's own Days Payable has ranged from 54.43 to 5,910.19 over the past decade. While the company's 10-year median is 251.00 vs. the industry median of 90.22, Polska Grupa Hutnicza has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polska Grupa Hutnicza's current Days Payable of 505.68 is 460.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Polska Grupa Hutnicza and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polska Grupa Hutnicza's current Days Payable is 505.68, which is 101% above median its own 10-year median of 251.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polska Grupa Hutnicza stock overvalued right now?
Based on GuruFocus' analysis, Polska Grupa Hutnicza (WAR:PGH) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.31, compared to a current price of zł3.97 — trading 1180.6% above its estimated fair value. The current Days Payable is 505.68, which is 101% above median its 10-year median of 251.00 and 460.5% above the Drug Manufacturers industry median of 90.22. Polska Grupa Hutnicza's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Polska Grupa Hutnicza (WAR:PGH), the current Days Payable is 505.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polska Grupa Hutnicza (WAR:PGH) Overvalued in 2026?
Based on GuruFocus' analysis, Polska Grupa Hutnicza stock appears to be overvalued.
The current stock price of zł3.97 is trading 1180.6% above its estimated GF Value™ of zł0.31.
GuruFocus considers Polska Grupa Hutnicza to be Significantly Overvalued.
Key valuation signals for WAR:PGH:
Days Payable: 505.68 (101% above median its 10-year median of 251.00)
GF Value™: zł0.31 vs. price of zł3.97 (1180.6% above fair value)
Industry Position: 460.5% above the Drug Manufacturers median (#94 of 926)
No single metric tells the full story. See the WAR:PGH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemp & Health SA is engaged in hemp and cannabis cultivation. The company processes harvested crops such as CBD and CBG, used for the production of white labels and private labels oils, creams, dried herbs and liquids for vaporization.
31GF Score
Get the complete analysis for WAR:PGH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PGH has been successfully added to your 
